Home

  • Order to parcel locker

    Order to parcel locker

  • easy pay

    easy pay
  • Oncofertility
  • Reduced price
Kaplan & Sadock's Pocket Handbook of Psychiatric Drug Treatment

See next edition:

Kaplan and Sadock's Pocket Handbook of Psychiatric Drug Treatment
Kaplan and Sadock's Pocket Handbook of Psychiatric Drug Treatment

Kaplan & Sadock's Pocket Handbook of Psychiatric Drug Treatment

9781609139681
296.10 zł
266.49 zł Save 29.61 zł Tax included
Lowest price within 30 days before promotion: 266.49 zł
Quantity
Product unavailable
Out of print

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
Kaplan & Sadocks Pocket Handbook of Psychiatric Drug Treatment covers the entire spectrum of clinical drug therapy for adults, elderly adults, pregnant and nursing women, and children. Drugs are listed alphabetically, for quick navigation, and each drug entry includes name, molecular structure, dosing, pharmacological actions, indications and clinical applications, side effects and adverse/allergic reactions, and drug interactions. In the front are tables listing the chapters where each drug is discussed and the common disorders for which each is used. Color drug plates in the front help with rapid recognition of all major drugs.
Product Details
Lippincott Williams & Wilkins
48779
9781609139681
9781609139681

Data sheet

Publication date
2011
Issue number
5
Cover
paperback
Pages count
320
Dimensions (mm)
127 x 203
  •  Contents
    Preface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . vii
    Acknowledgments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ix
    1. General Principles of Psychopharmacology . . . . . . . . . . . . . . . . . . . . . . . . . 1
    2. α2-Adrenergic Receptor Agonists, α1-Adrenergic Receptor Antagonists:
    Clonidine, Guanfacine, Minipress and Yohimbine. . . . . . . . . . . . . . . . . . . . 25
    3. β-Adrenergic Receptor Antagonists . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
    4. Anticholinergics and Amantadine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
    5. Anticonvulsants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
    6. Antihistamines . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
    7. Barbiturates and Similarly Acting Drugs . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
    8. Benzodiazepines and Drugs Acting on Benzodiazepine Receptors . . . . . 68
    9. Bupropion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
    10. Buspirone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85
    11. Calcium Channel Inhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89
    12. Carbamazepine and Oxcarbazepine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93
    13. Cholinesterase Inhibitors and Memantine . . . . . . . . . . . . . . . . . . . . . . . . . . . 101
    14. Disulfiram and Acamprosate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 108
    15. Dopamine Receptor Agonists and Precursors . . . . . . . . . . . . . . . . . . . . . . . . 113
    16. Dopamine Receptor Antagonists (First Generation Antipsychotics) . . . . 118
    17. Lamotrigine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 137
    18. Lithium . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141
    19. Melatonin Agonists: Ramelton and Melatonin . . . . . . . . . . . . . . . . . . . . . . . 157
    20. Mirtazapine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 161
    21. Monoamine Oxidase Inhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 164
    22. Nefazodone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 171
    23. Opioid Receptor Agonists: Methadone and Buprenorphine . . . . . . . . . . . 174
    24. Opioid Receptor Antagonists: Naltrexone, Nalmefene, and Naloxone . . 181
    25. Phosphodiesterase-5 Inhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 188
    26. Selective Serotonin–Norepinephrine Reuptake Inhibitors . . . . . . . . . . . . . 193
    27. Selective Serotonin Reuptake Inhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . . . 200
    28. Serotonin–Dopamine Antagonists and Similarly Acting Drugs
    (Second Generation or Atypical Antipsychotics) . . . . . . . . . . . . . . . . . . . . . 217
    29. Sympathomimetics and Related Drugs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 238
    30. Thyroid Hormones . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 248
    31. Trazodone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 251
    32. Tricyclics and Tetracyclics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 255
    33. Valproate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 266
    34. Nutritional Supplements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 274
    35. Intoxication and Overdose . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 288
    Index. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 299
    About the Authors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 315

See next edition:

Kaplan and Sadock's Pocket Handbook of Psychiatric Drug Treatment
Kaplan and Sadock's Pocket Handbook of Psychiatric Drug Treatment
Comments (0)

  • Frequently purchased together

    No products available